CONTROLLED SUBSTANCES

Report: DEA causing controlled substances shortages

The Drug Enforcement Agency has not responded to manufacturers' applications in a timely fashion. More

TREATMENT AREAS

Higher oncology costs driven by practice setting

The good news is that the five-year relative survival rates for major cancers are rising. More

EDITOR'S CHOICE

Who will fill gaps in healthcare delivery and control costs?

Provider status will enable pharmacists to give basic care for UTIs, headaches, simple rashes, etc. More

Inside The Latest Issue

ACA opens the door to value-based care Why pharmacists should endorse healthcare for all Relationship building key to interprofessional practice

May 14, 2015

IN CASE YOU MISSED IT

New guide offers naloxone-dispensing information for pharmacists

New forum created to expand access to biosimilars

ACO model saves CMS $384 million

Continuing education

MTM essentials for asthma management: Part 2

MTM essentials for asthma management: Part 1

Updates on the national guidelines for diabetes management and related disorders

Get the free app!

UBM MEDICA